Skip to content

TO STUDY THE EFFECT OF DARVYADI YONIVARTI (VAGINAL SUPPOSITORY) IN TREATMENT OF CERVICAL EROSION (GARBHASAYAGAT MUKHAVRANA)

A SINGLE ARM CLINICAL STUDY TO EVALUATE THE EFFICACY OF DARVYADI YONIVARTI (VAGINAL SUPPOSITORY) IN MANAGEMENT OF CERVICAL EROSION (KARNINI YONIVYAPAD)

Status
Active, not recruiting
Phases
Phase 2Phase 3
Study type
Interventional
Source
CTRI
Registry ID
CTRI/2021/11/037981
Enrollment
40
Registered
2021-11-12
Start date
Unknown
Completion date
Unknown
Last updated
2022-02-21

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Health Condition 1: N86- Erosion and ectropion of cervix uteri

Interventions

None listed

Sponsors

DR MOHINI GREWAL
Lead Sponsor

Eligibility

Inclusion criteria

Inclusion criteria: ALL MARRIED WOMEN HAVING CERVICAL EROSION WITH LEUCORRHOEA PATIENTS WITH FOLLOWING SYMPTOMS OF LEUCORRHOEA ,LOWER ABDOMINAL PAIN, LOWER BACKACHE AGE GROUP OF 18 TO 45 YEARS

Exclusion criteria

Exclusion criteria: PATIENTS OF GENITAL CANCER, PREGNANCY, SEXUALLY TRANSMITTED DISEASE , DYSFUNCTIONAL UTERINE BLEEDING , MENORRHAGIA, UNCONTROLLED DIABETES MELLITUS

Design outcomes

Primary

MeasureTime frame
TO STUDY THE EFFICACY OF DARVYADI YONIVARTI IN REDUCTION OF CERVICAL EROSION (KARNINI YONIVYAPAD)Timepoint: DARVYADI YONIVARTI ( VAGINAL SUPPOSITORY) WILL BE ADVISED DEEP VAGINALLY ON BEDTIME FOR 15 DAYS TO 40 PATIENTS. FOLLOW UPS WILL BE TAKEN ON 7TH AND 15 TH DAY. TOTAL DURATION OF CASE STUDY WILL BE 15 DAYS.

Secondary

MeasureTime frame
TO OBSERVE THE ADVERSE EFFECT OF HERBAL VAGINAL SUPPOSITORY FOR CERVICAL EROSION.Timepoint: DARVYADI YONIVARTI ( VAGINAL SUPPOSITORY) WILL BE ADVISED DEEP VAGINALLY ON BEDTIME FOR 15 DAYS TO 40 PATIENTS. FOLLOW UPS WILL BE TAKEN ON 7TH AND 15 TH DAY. TOTAL DURATION OF CASE STUDY WILL BE 15 DAYS.

Countries

India

Contacts

Public ContactDR PRADNYA VIJAY SHIRKE

DR D Y PATIL COLLEGE OF AYURVED AND RESEARCH CENTRE PIMPRI PUNE 411018

pradnyashirke2@gmail.com9623446110

Outcome results

None listed

Source: CTRI (via WHO ICTRP) · Data processed: Feb 4, 2026